NZ630795A - Crystalline form of vsn16 - Google Patents
Crystalline form of vsn16Info
- Publication number
- NZ630795A NZ630795A NZ630795A NZ63079514A NZ630795A NZ 630795 A NZ630795 A NZ 630795A NZ 630795 A NZ630795 A NZ 630795A NZ 63079514 A NZ63079514 A NZ 63079514A NZ 630795 A NZ630795 A NZ 630795A
- Authority
- NZ
- New Zealand
- Prior art keywords
- crystalline form
- disclosed
- vsn16
- compound
- free base
- Prior art date
Links
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000012458 free base Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/69—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1300903.0A GB201300903D0 (en) | 2013-01-18 | 2013-01-18 | Crystalline Form |
| PCT/GB2014/050127 WO2014111720A1 (en) | 2013-01-18 | 2014-01-17 | Crystalline form of vsn16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ630795A true NZ630795A (en) | 2016-07-29 |
Family
ID=47843537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ630795A NZ630795A (en) | 2013-01-18 | 2014-01-17 | Crystalline form of vsn16 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9682924B2 (OSRAM) |
| EP (1) | EP2945619B1 (OSRAM) |
| JP (1) | JP2016505036A (OSRAM) |
| CN (1) | CN105142626A (OSRAM) |
| CA (1) | CA2897524A1 (OSRAM) |
| GB (1) | GB201300903D0 (OSRAM) |
| NZ (1) | NZ630795A (OSRAM) |
| RU (1) | RU2015134560A (OSRAM) |
| WO (1) | WO2014111720A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3256112A1 (en) * | 2015-02-13 | 2017-12-20 | Canbex Therapeutics Limited | Compounds for treating disorders associated with bk channel modulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0403864D0 (en) * | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
| GB0903956D0 (en) | 2009-03-06 | 2009-04-22 | Ucl Business Plc | Process |
-
2013
- 2013-01-18 GB GBGB1300903.0A patent/GB201300903D0/en not_active Ceased
-
2014
- 2014-01-17 RU RU2015134560A patent/RU2015134560A/ru not_active Application Discontinuation
- 2014-01-17 JP JP2015553165A patent/JP2016505036A/ja active Pending
- 2014-01-17 CN CN201480013204.7A patent/CN105142626A/zh active Pending
- 2014-01-17 WO PCT/GB2014/050127 patent/WO2014111720A1/en not_active Ceased
- 2014-01-17 EP EP14702299.0A patent/EP2945619B1/en active Active
- 2014-01-17 US US14/760,592 patent/US9682924B2/en active Active
- 2014-01-17 NZ NZ630795A patent/NZ630795A/en not_active IP Right Cessation
- 2014-01-17 CA CA2897524A patent/CA2897524A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015134560A (ru) | 2017-02-28 |
| CA2897524A1 (en) | 2014-07-24 |
| EP2945619B1 (en) | 2019-05-08 |
| WO2014111720A1 (en) | 2014-07-24 |
| GB201300903D0 (en) | 2013-03-06 |
| EP2945619A1 (en) | 2015-11-25 |
| US20150353476A1 (en) | 2015-12-10 |
| US9682924B2 (en) | 2017-06-20 |
| CN105142626A (zh) | 2015-12-09 |
| JP2016505036A (ja) | 2016-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| MX2015017861A (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
| EP4643945A8 (en) | Neuroactive steroids and methods of use thereof | |
| WO2016044641A3 (en) | Carm1 inhibitors and uses thereof | |
| MX390302B (es) | Oxiesteroles y metodos de uso de los mismos | |
| MX2021008356A (es) | Inhibidores de jak2 y alk2 y metodos para su uso. | |
| IN2014MN02106A (OSRAM) | ||
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| EP4582424A3 (en) | 1,2-naphthoquinone derivative and method for preparing same | |
| PH12016500394A1 (en) | Polymorphic form of pyrrole derivative and intermediate thereof | |
| PH12018500378A1 (en) | Novel annelated phenoxyacetamides | |
| MX390763B (es) | Compuestos de tetraciclina | |
| MX2015013224A (es) | Inhibidores macrociclicos y biciclicos del virus de la hepatitis c. | |
| WO2015002755A3 (en) | Compounds for the treatment of malaria | |
| MX2018015990A (es) | Compuestos terapeuticos. | |
| PH12015501056A1 (en) | 2-pyridone compound | |
| PH12015501696B1 (en) | Prophylactic or therapeutic drug for constipation | |
| WO2015102017A8 (en) | Processes for the preparation of lorcaserin | |
| WO2016022700A3 (en) | Tlr-independent small molecule adjuvants | |
| MX2015017124A (es) | Combinacion de ro5503781, capecitabina y oxaliplatino para la terapia para el cancer. | |
| GR1008380B (el) | Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου | |
| CA2905957C (en) | Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 17 JAN 2019 BY DR. STEFFEN SCHWARZ IPRIS AG Effective date: 20180112 |
|
| LAPS | Patent lapsed |